UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Oct

    31

    Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

    Oct

    29

    Looking to The Future: How UCB is Supporting Dermatology Patients Now and Tomorrow

    Read more from UCB's Head of U.S. Immunology, Camille Lee, who shares how UCB is supporting dermatology patients now throughout the pandemic and in the future. 

    Oct

    29

    UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology

    Oct

    26

    Finding Success as a Scientist: Women and Diversity in Science with Cierra Spencer

    UCB is proud to have scientists like Cierra Spencer, PhD, who are driven and share our vision to create an environment that encourages innovation, expertise, and #diversity. Cierra shares the story of how she found her passion for the pharmaceutical industry and some advice for other women in science as they pursue their career. 

    Oct

    23

    UCB Women’s Health Fellowship Program

    As the nationwide shortage of rheumatologists continues, UCB would like to encourage the development of future Thought Leaders in key areas of unmet need. By creating additional training opportunities for current rheumatology fellows, UCB hopes specifically to increase women’s health expertise in the rheumatology community. This program will support the year-long training of up to three rheumatology fellows ($100,000 each) with a specialized focus on women’s health-related issues, specifically in the context of inflammatory diseases.  

    Oct

    22

    The Path is Not Always Linear

    UCB’s Iram Hasan, Senior Manager, Regulatory Affairs, understands the importance of being flexible and attributes the milestones in her career path to this mentality. Read more from Iram on how keeping an open mind led her to launching UCB’s first PharmD fellowship program in Global Regulatory Affairs (GRA).

    Oct

    21

    New approaches to STEM support during COVID-19

    UCB is committed to investing in STEM education across the U.S. because we recognize the important role of the biopharmaceutical industry to inspire and develop a sustainable and diverse STEM workforce now and in the future. With this, we also know there are many challenges teachers and students may face when developing STEM programs, especially during a pandemic. As such, UCB has looked for different approaches to expand our investment to better support them. 

    Oct

    13

    Celebrating Hispanic Heritage Month with New Employee Resource Group RAIZ

    As UCB continues to grow as a global company, the diversity and inclusivity of the culture continues to expand as well by creating new opportunities of connection both within and beyond UCB’s employee community. In commemoration of Hispanic Heritage Month, UCB is proud to offer a new employee resource group (ERG), RAIZ, dedicated to the many Hispanic and Latino UCB colleagues. 

    Oct

    12

    Curiosity and Engagement are Key, Not Gender: Women & Diversity in Science with Yuan Wang

    As a Senior Principal Data Scientist, Yuan Wang, PhD, uses her strength for uniting different people in her field to drive innovation at UCB, and encourages her team to value the importance of diversity in collaboration. Read her story. 

    Oct

    08

    UCB Researchers Virtually Advocate for Innovation

    Last week, UCB researchers from across the country gathered virtually for the PhRMA Researcher Fly-In where more than 70 industry researchers engaged with Members of Congress. Read their stories.